Review
Accepted on 12 Jan 2026
Research progress on the mechanism of panax notoginseng saponin in the treatment of atherosclerosis
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
Type at least 3 characters
124 articles
articles
Original Research
Published on 09 Jan 2026
Protosappanin A protects against pathological cardiac hypertrophy by inhibiting oxidative stress and NLRP3 inflammasome-mediated pyroptosis via activation of the Nrf2 signaling pathway
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2025.1682641
- 343 views
Original Research
Accepted on 07 Jan 2026
Astragaloside IV prevents calpain-1-mediated cardiac hypertrophy and fibrosis induced by diabetes
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
Original Research
Accepted on 07 Jan 2026
Qing-Xin-Jie-Yu Granule prevents myocardial infarction-induced apoptosis via inhibition of p38 MAPK pathway
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
Original Research
Published on 06 Jan 2026
Helianthus Annuus L. ameliorates atherosclerosis-induced myocardial infarction via inhibiting inflammation and oxidative stress
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2025.1744283
- 495 views
Brief Research Report
Published on 06 Jan 2026
Plasma pharmacokinetics of the combination of potassium chloride extended-release tablets and potassium citrate granules in patients with cardiovascular emergencies
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2025.1636090
- 348 views
Original Research
Accepted on 02 Jan 2026
Real-World Effectiveness of SGLT2 Inhibitors in Patients with HF and ESKD: A Multicenter Cohort Study
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
- 382 views
Original Research
Accepted on 02 Jan 2026
Sex Differences in Lymphatic Response to Estrogen Shape Atherosclerosis in High-Risk Mice
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
- 316 views
Original Research
Accepted on 29 Dec 2025
Network Pharmacological Analysis, Mendelian Randomization Analysis and Animal Experimental reveal the mechanism of Wenxin Granules in inhibiting heart failure after myocardial infarction: Apoptosis and Inflammation
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
- 170 views
Review
Published on 09 Dec 2025
Cardiovascular safety pharmacology: beyond arrhythmic risk assessment
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2025.1623644
- 684 views
Clinical Trial
Published on 08 Dec 2025
Assessing the cardiovascular and potassium lowering effects of levalbuterol compared to albuterol: a randomized control trial
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2025.1463999
- 796 views
Review
Published on 21 Nov 2025
Targeting the Notch signaling pathway: molecular mechanisms and therapeutic strategies for cardiac repair after myocardial infarction
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2025.1669362
- 1,149 views
Mini Review
Published on 27 Oct 2025
The role of cardiac lymphatic dysfunction in the progression of myocarditis
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2025.1659309
- 1,484 views
Review
Published on 23 Oct 2025
Nanoparticle-based drug delivery systems targeting inflammatory immune mechanisms in acute myocardial infarction: current advances and perspectives
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2025.1657300
- 1,989 views
Review
Published on 05 Sep 2025
Medicinal plants administered to control hypertension in Ethiopia: ethnomedicine, pharmacology, nutraceutical, phytochemistry, toxicology, and policy perspectives
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2025.1514911
- 5,767 views
Original Research
Published on 12 Aug 2025
Effects of angiotensin receptor–neprilysin inhibition on myocardial energy metabolism and prognosis in patients with acute myocardial infarction complicated by heart failure
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2025.1550624
- 2,229 views
Original Research
Published on 12 Aug 2025
Salidroside ameliorates abnormalities in electrophysiological indices induced by perfusion of the heart with low-potassium solutions
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2025.1628940
- 2,258 views
Case Report
Published on 23 Jul 2025
Treatment of infective endocarditis caused by Enterococcus faecalis with a combination of penicillin G and ceftriaxone: a case report and literature review
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2025.1539372
- 3,841 views
Review
Published on 14 Jul 2025
The role of Nrf2 signaling pathway in diabetic cardiomyopathy: from pathogenesis to traditional Chinese medicine interventions
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2025.1492499
- 3,487 views
- 1 citation
Systematic Review
Published on 10 Jul 2025
A systematic review and network meta-analysis of cardiovascular safety of benzbromarone compared to febuxostat and allopurinol in patients with gout
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2025.1541307
- 4,208 views
- 1 citation
Original Research
Published on 04 Jul 2025
Herb pair of Astragali Radix-Descurainiae Semen attenuate heart failure through the myosin VI-Tom1 complex mediated autophagy
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2025.1599746
- 2,453 views
Review
Published on 01 Jul 2025
The therapeutic effects of natural organosulfur compounds on atherosclerosis and their potential mechanisms: a comprehensive review
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2025.1599154
- 3,189 views
- 2 citations
Brief Research Report
Published on 30 Jun 2025
Clinical outcomes of pharmacological therapies for heart failure in Black vs. White populations: a meta-analysis of randomized controlled trials of heart failure treatment
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2025.1482311
- 1,851 views
Original Research
Published on 30 Jun 2025
CLU, FOS, and CXCL8 as diagnostic biomarkers for heart failure progression post-acute myocardial infarction: an integrated RNA-Seq and multi-machine learning study
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2025.1611668
- 2,513 views
- 1 citation